RUMATRYP (Tablet)

RUMATRYP is a high-potency tablet formulation containing Trypsin 48 mg + Bromelain 90 mg + Rutoside Trihydrate 100 mg.

Composition: Trypsin 48 mg + Bromelain 90 mg + Rutoside Trihydrate 100 mg
Dosage Form: Tablet

Clinical Pharmacology

RUMATRYP combines proteolytic enzymes with rutoside. The formulation is intended to provide adjunctive support in inflammatory and traumatic soft-tissue conditions.

Indications & Usage

May be used as an adjunct in:

• Soft-tissue inflammation
• Traumatic swelling
• Post-operative edema
• Musculoskeletal injuries
• Sprains and strains
• Sports-related soft-tissue injuries
• Dental and surgical inflammatory conditions

Contraindications

Hypersensitivity to any component. Caution in patients with bleeding disorders.

Warnings & Precautions

Use cautiously with anticoagulants or antiplatelet medicines and before surgical procedures.

Drug Interactions

Potential additive bleeding effects with anticoagulants and antiplatelet agents.

Pregnancy & Lactation

Use only under medical supervision.

Dosage & Administration

As directed by the physician.

Adverse Reactions

Nausea, gastrointestinal discomfort, diarrhea and hypersensitivity reactions.

Therapeutic Focus: Proteolytic Enzymes / Inflammation Management | Primary Specialty: Orthopedics